Abstract
Background
Proteome‐wide
Mendelian
randomization
studies
have
been
increasingly
utilized
to
identify
potential
drug
targets
for
diseases.
We
aimed
therapeutic
migraine
and
its
subtypes
through
the
application
of
co‐localization
analysis
methods.
Methods
cis‐
protein
quantitative
trait
loci
data
1378
plasma
proteins
available
from
two
with
7213
individuals
35,559
individuals,
respectively.
Summary
were
obtained
a
genetic
study
involving
up
1,339,303
individuals.
Proteins
that
passed
both
discovery
validation
analysis,
sensitivity
heterogeneity
test,
pleiotropy
associated
≥2
outcomes,
received
strong
support
(PP.H4.abf
≥0.80)
classified
as
tier
1
proteins.
Results
identified
three
(LRP11,
ITIH1,
ADGRF5),
whose
genes
not
previously
causal
in
studies.
LRP11
was
significantly
risk
any
(OR
[odds
ratio]
=
0.968,
95%
CI
[confidence
interval]
0.955–0.981,
p
1.27
×
10
−6
)
significantly/suggestively
subtypes.
ITIH1
1.044,
1.024–1.065,
1.08
−5
visual
disturbances.
ADGRF5
0.964,
0.946–0.982,
8.74
suggestively
aura.
The
effects
further
replicated
using
cerebrospinal
fluid
data.
Apart
ADGRF5,
there
no
evidence
adverse
consequences
when
modulating
levels.
also
another
four
(PLCG1,
ARHGAP25,
CHGA,
MANBA)
levels,
their
reported
by
previous
Conclusions
found
compelling
suggestive
could
be
promising
treatment
without
significant
consequences.
corresponding
Future
are
needed
confirm
role
these
explore
underlying
mechanisms.
The Journal of Headache and Pain,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: April 3, 2023
The
neuropeptides
calcitonin
gene-related
peptide
(CGRP)
and
pituitary
adenylate
cyclase-activating
polypeptide
(PACAP)
have
emerged
as
mediators
of
migraine
pathogenesis.
Both
are
vasodilatory
peptides
that
can
cause
migraine-like
attacks
when
infused
into
people
symptoms
injected
rodents.
In
this
narrative
review,
we
compare
the
similarities
differences
between
in
both
their
clinical
preclinical
actions.
A
notable
difference
is
PACAP,
but
not
CGRP,
causes
premonitory-like
patients.
found
distinct,
overlapping
areas
relevant
to
migraine,
most
notably
with
prevalence
CGRP
trigeminal
ganglia
PACAP
sphenopalatine
ganglia.
rodents,
two
share
activities,
including
vasodilation,
neurogenic
inflammation,
nociception.
Most
strikingly,
similar
rodents
manifested
light
aversion
tactile
allodynia.
Yet,
appear
act
by
independent
mechanisms
possibly
distinct
intracellular
signaling
pathways.
complexity
these
pathways
magnified
existence
multiple
receptors
may
contribute
Based
on
differences,
suggest
its
provide
a
rich
set
targets
complement
augment
current
CGRP-based
therapeutics.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(2), P. 337 - 337
Published: Jan. 18, 2025
Background:
Migraine,
a
prevalent
neurovascular
disorder,
affects
millions
globally
and
is
associated
with
significant
morbidity.
Emerging
evidence
suggests
crucial
role
of
the
gut
microbiota
adipose
tissue
in
modulation
migraine
pathophysiology,
particularly
through
mechanisms
involving
neuroinflammation
metabolic
regulation.
Material
Methods:
A
narrative
review
literature
from
2000
to
2024
was
conducted
using
PubMed
database.
Studies
addressing
relationships
between
microbiota,
tissue,
migraine—including
dietary
interventions
their
impact—were
analyzed.
Results:
The
findings
highlight
bidirectional
gut–brain
axis,
influencing
via
metabolites
such
as
short-chain
fatty
acids
(SCFAs).
Obesity
exacerbates
severity
chronic
inflammation
dysregulation
adipocytokines
like
leptin
adiponectin.
Dietary
patterns,
low
glycemic
index
diets
Mediterranean
diets,
use
prebiotics,
probiotics,
postbiotics
show
potential
management.
Conclusions:
This
underscores
need
for
integrative
approaches
targeting
microbiota–gut–brain
axis
therapy.
Future
studies
should
explore
longitudinal
effects
personalized
optimize
outcomes.
The Journal of Headache and Pain,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: Sept. 10, 2023
Targeting
CGRP
has
proved
to
be
efficacious,
tolerable,
and
safe
treat
migraine;
however,
many
patients
with
migraine
do
not
benefit
from
drugs
that
antagonize
the
CGRPergic
system.
Therefore,
this
review
focuses
on
summarizing
general
pharmacology
of
different
types
treatments
currently
available,
which
target
directly
or
indirectly
receptor
its
ligand.
Moreover,
latest
evidence
regarding
selectivity
site
action
small
molecule
antagonists
(gepants)
monoclonal
antibodies
is
critically
discussed.
Finally,
reasons
behind
non-responders
anti-CGRP
rationale
for
combining
and/or
switching
between
these
therapies
are
addressed.
The Journal of Headache and Pain,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: June 27, 2023
Abstract
Background
Migraine
is
a
disabling
and
chronic
neurovascular
headache
disorder.
Trigeminal
vascular
activation
release
of
calcitonin
gene-related
peptide
(CGRP)
play
pivotal
role
in
the
pathogenesis
migraine.
This
knowledge
has
led
to
development
CGRP(-receptor)
therapies.
Yet,
substantial
proportion
patients
do
not
respond
these
treatments.
Therefore,
alternative
targets
for
future
therapies
are
warranted.
The
current
narrative
review
provides
comprehensive
overview
pathophysiological
possible
non-CGRP
Findings
We
covered
metabotropic
receptors
(pituitary
adenylate
cyclase-activating
polypeptide
(PACAP),
vasoactive
intestinal
(VIP),
amylin,
adrenomedullin),
intracellular
(nitric
oxide
(NO),
phosphodiesterase-3
(PDE3)
-5
(PDE5)),
ion
channels
(potassium,
calcium,
transient
receptor
potential
(TRP),
acid-sensing
(ASIC)).
majority
were
able
induce
migraine-like
attacks,
except
(i)
calcium
channels,
as
it
yet
directly
target
elucidate
their
precise
involvement
migraine;
(ii)
TRP
which
can
non-migraine
headache;
(iii)
ASICs,
inducing
migraine
attacks
been
investigated
thus
far.
Drugs
that
its
exist
PACAP,
NO,
potassium,
TRP,
ASIC
channels.
No
selective
drugs
other
targets,
however,
some
existing
(migraine)
treatments
appear
indirectly
antagonize
responses
adrenomedullin,
against
potassium
only
PAC
1
antibody
have
tested
treatment,
albeit
with
ambiguous
results.
Conclusion
While
research
on
drug
efficacious
therapies,
human
provocation
studies
using
provided
valuable
insight
into
underlying
mechanisms
headaches
auras.
Further
needed
non-responders
targeted
ultimate
aim
pave
way
towards
headache-free
all
patients.
Biomolecules,
Journal Year:
2023,
Volume and Issue:
13(5), P. 838 - 838
Published: May 15, 2023
Calcitonin
gene-related
peptide
(CGRP)
has
37
amino
acids.
Initially,
CGRP
had
vasodilatory
and
nociceptive
effects.
As
research
progressed,
evidence
revealed
that
the
peripheral
nervous
system
is
closely
associated
with
bone
metabolism,
osteogenesis,
remodeling.
Thus,
bridge
between
skeletal
muscle
system.
can
promote
inhibit
resorption,
vascular
growth,
regulate
immune
microenvironment.
The
G
protein-coupled
pathway
vital
for
its
effects,
while
MAPK,
Hippo,
NF-κB,
other
pathways
have
signal
crosstalk,
affecting
cell
proliferation
differentiation.
current
review
provides
a
detailed
description
of
repair
effects
CGRP,
subjected
to
several
therapeutic
studies,
such
as
drug
injection,
gene
editing,
novel
materials.
Cells,
Journal Year:
2024,
Volume and Issue:
13(13), P. 1098 - 1098
Published: June 25, 2024
Migraine
is
a
debilitating
neurological
disorder
characterized
by
recurring
episodes
of
throbbing
headaches
that
are
frequently
accompanied
sensory
disturbances,
nausea,
and
sensitivity
to
light
sound
[...]
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(11)
Published: March 7, 2024
The
somatosensory
nervous
system
surveils
external
stimuli
at
barrier
tissues,
regulating
innate
immune
cells
under
infection
and
inflammation.
roles
of
sensory
neurons
in
controlling
the
adaptive
system,
more
specifically
immunity
to
microbiota,
however,
remain
elusive.
Here,
we
identified
a
mechanism
for
direct
neuroimmune
communication
between
commensal-specific
T
lymphocytes
mediated
by
neuropeptide
calcitonin
gene–related
peptide
(CGRP)
skin.
Intravital
imaging
revealed
that
are
close
proximity
cutaneous
nerve
fibers
vivo.
Correspondingly,
observed
upregulation
receptor
CGRP,
RAMP1,
CD8
+
induced
skin
commensal
colonization.
CGRP–RAMP1
signaling
axis
functions
constrain
Type
17
responses
moderate
activation
status
microbiota-reactive
homeostasis.
As
such,
modulation
shapes
overall
epithelium,
thereby
impacting
outcome
insults
such
as
wounding.
ability
control
microbiota
via
underscores
various
layers
regulation
multisystem
coordination
required
optimal
cell
steady
state
pathology.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Feb. 5, 2024
Emerging
evidence
suggests
that
nerves
within
the
tumor
microenvironment
play
a
crucial
role
in
regulating
angiogenesis.
Neurotransmitters
and
neuropeptides
released
by
can
interact
with
nearby
blood
vessels
cells,
influencing
their
behavior
modulating
angiogenic
response.
Moreover,
nerve-derived
signals
may
activate
signaling
pathways
enhance
production
of
pro-angiogenic
factors
microenvironment,
further
supporting
vessel
growth
around
tumors.
The
intricate
network
communication
between
neural
constituents
vascular
system
accentuates
potential
therapeutically
targeting
neural-mediated
as
an
innovative
strategy
to
modulate
angiogenesis
and,
consequently,
neoplastic
proliferation.
Hereby,
we
review
studies
evaluate
precise
molecular
interplay
clinical
ramifications
manipulating
elements
for
purpose
anti-angiogenic
therapeutics
scope
cancer
treatment.
The Journal of Headache and Pain,
Journal Year:
2024,
Volume and Issue:
25(1)
Published: April 29, 2024
Abstract
Background
Calcitonin
gene-related
peptide
(CGRP)
is
the
most
promising
candidate
to
become
first
migraine
biomarker.
However,
literature
shows
clashing
results
and
suggests
a
methodological
source
for
such
discrepancies.
We
aimed
investigate
some
of
these
factors
evaluate
actual
role
CGRP
as
Methods
Previous
experimental
part,
we
performed
review
articles
measuring
in
patients.
Using
our
399
bio-bank
sera
samples,
series
experiments
test
validity
different
ELISA
kits
employed,
time
sample
processing,
long-term
storage,
sampling
rest
or
after
moderate
exercise.
Analysis
in-house
data
was
analyse
average
levels
effect
sex
age.
Results
Literature
high
variability
terms
study
design,
determination
methods,
conclusions
obtained
by
studies
including
determinations
measurements
depends
on
method
specific
kit
also
isoform
detected,
showing
completely
ranges
concentrations.
Alpha-CGRP
beta-CGRP
had
median
with
IQR
37.5
(28.2–54.4)
4.6
(2.4–6.4)pg/mL,
respectively.
content
preserved
serum
within
24
hours
when
samples
are
stored
at
4°C
clotting
immediate
centrifugation.
Storages
-80°C
more
than
6
months
result
decrease
levels.
Moderate
exercise
prior
blood
extraction
does
not
modulate
concentration
peptide.
Age
positively
correlates
men
have
higher
alpha-CGRP
women.
Conclusions
present
valuable
information
serum.
suitability
should
be
tested
experiments.
Alpha
analysed
separately
they
can
show
behaviours
even
same
condition.
Samples
processed
24-h
window
if
been
kept
before
assayed.
Patients
do
need
unless
high-endurance
For
comparative
studies,
age
accounted
parameters
impact
Graphical
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(2), P. 163 - 163
Published: Jan. 30, 2024
Migraine
is
a
highly
prevalent
neurological
disorder.
Among
the
risk
factors
identified,
psychiatric
comorbidities,
such
as
depression,
seem
to
play
an
important
role
in
its
onset
and
clinical
course.
Patients
with
migraine
are
2.5
times
more
likely
develop
depressive
disorder;
this
becomes
even
higher
patients
suffering
from
chronic
or
aura.
This
relationship
bidirectional,
since
depression
also
predicts
earlier/worse
of
migraine,
increasing
chronicity
and,
consequently,
requiring
healthcare
expenditure
compared
alone.
All
these
data
suggest
that
may
share
overlapping
biological
mechanisms.
Herein,
review
explores
topic
further
detail:
firstly,
by
introducing
common
epidemiological
for
comorbidity;
secondly,
focusing
on
providing
cumulative
evidence
aspects,
particular
emphasis
serotoninergic
system,
neuropeptides
calcitonin-gene-related
peptide
(CGRP),
pituitary
adenylate
cyclase-activating
polypeptide
(PACAP),
substance
P,
neuropeptide
Y
orexins,
sexual
hormones,
immune
system;
lastly,
remarking
future
challenges
required
elucidate
etiopathological
mechanisms
updated
information
regarding
new
key
targets
pharmacological
treatment
entities.